Cas:121307-79-7 4-(trifluoromethyl)-1H-pyridine-2-thione manufacturer & supplier

Chemical Name:4-(trifluoromethyl)-1H-pyridine-2-thione

CAS.NO:121307-79-7

Synonyms:2(1H)-Pyridinethione,4-(trifluoromethyl);4-(Trifluoromethyl)pyridine-2-thiol;4-trifluoromethylpyridine-2(1H)-thione;4-trifluoromethylpyridin-2(1H)-thione

Molecular Formula:C₆H₄F₃NS

Molecular Weight:179.16300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:214.1ºC at 760 mmHg

Density:1.391g/cm3

Index of Refraction:1.494

PSA:51.69000

Exact Mass:179.00200

LogP:2.38910

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2(1H)-Pyridinethione,4-(trifluoromethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-trifluoromethylpyridin-2(1H)-thione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-trifluoromethylpyridine-2(1H)-thione Use and application,4-(Trifluoromethyl)pyridine-2-thiol technical grade,usp/ep/jp grade.

Related News: The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus. 4-(trifluoromethyl)-1H-pyridine-2-thione manufacturer Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. 4-(trifluoromethyl)-1H-pyridine-2-thione supplier Darzalex has its own VRd combo trials, dubbed PERSEUS and CEPHEUS, which are testing a newly approved under-the-skin version of the J&J drug called Darzalex Faspro. The CEPHEUS trial appears to have just completed its primary analysis, according to a listing on ClinicalTrials.gov. 4-(trifluoromethyl)-1H-pyridine-2-thione vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. 4-(trifluoromethyl)-1H-pyridine-2-thione factory DMF is the main management method for APIs in developed countries in Europe and the United States. Under the DMF system, API companies can submit DMF filing documents to the regulatory authority at any time, but the regulatory authority will not conduct technical reviews on them. When the drug is administered, the regulatory authority will associate and review the drug substance and the preparation.